A citation-based method for searching scientific literature

Carlos Cepeda, Amaal J Starling, Nanping Wu, Oanh K Nguyen, Besim Uzgil, Takahiro Soda, Veronique M André, Marjorie A Ariano, Michael S Levine. J Neurosci Res 2004
Times Cited: 102







List of co-cited articles
1503 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
51


Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Carlos Cepeda, Raymond S Hurst, Christopher R Calvert, Elizabeth Hernández-Echeagaray, Oanh K Nguyen, Emily Jocoy, Lindsey J Christian, Marjorie A Ariano, Michael S Levine. J Neurosci 2003
253
45

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
232
32

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
246
31

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
30

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
740
29

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
120
29

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
937
25

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
25

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
587
25

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
25

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.
Michael S Levine, Carlos Cepeda, Miriam A Hickey, Sheila M Fleming, Marie-Françoise Chesselet. Trends Neurosci 2004
127
24

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
80
28

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
443
22


A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
J G Hodgson, N Agopyan, C A Gutekunst, B R Leavitt, F LePiane, R Singaraja, D J Smith, N Bissada, K McCutcheon, J Nasir,[...]. Neuron 1999
635
21

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
791
21

Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
G A Laforet, E Sapp, K Chase, C McIntyre, F M Boyce, M Campbell, B A Cadigan, L Warzecki, D A Tagle, P H Reddy,[...]. J Neurosci 2001
204
19

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
18


Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
J H Cha, C M Kosinski, J A Kerner, S A Alsdorf, L Mangiarini, S W Davies, J B Penney, G P Bates, A B Young. Proc Natl Acad Sci U S A 1998
412
18

Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
K P Murphy, R J Carter, L A Lione, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 2000
286
18

Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease.
Damian M Cummings, Austen J Milnerwood, Glenn M Dallérac, Verina Waights, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Kerry P S J Murphy. Hum Mol Genet 2006
88
20

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
337
18

Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.
Benjamin R Miller, Adam G Walker, Anand S Shah, Scott J Barton, George V Rebec. J Neurophysiol 2008
87
20

Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease.
Gary Lynch, Eniko A Kramar, Christopher S Rex, Yousheng Jia, Danielle Chappas, Christine M Gall, Danielle A Simmons. J Neurosci 2007
144
17

Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease.
M S Levine, G J Klapstein, A Koppel, E Gruen, C Cepeda, M E Vargas, E S Jokel, E M Carpenter, H Zanjani, R S Hurst,[...]. J Neurosci Res 1999
257
16

Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
J C Liévens, B Woodman, A Mahal, O Spasic-Boscovic, D Samuel, L Kerkerian-Le Goff, G P Bates. Neurobiol Dis 2001
217
16

Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
Marjorie A Ariano, Carlos Cepeda, Christopher R Calvert, Jorge Flores-Hernández, Elizabeth Hernández-Echeagaray, Gloria J Klapstein, Scott H Chandler, Neil Aronin, Marian DiFiglia, Michael S Levine. J Neurophysiol 2005
82
19

Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice.
Diego Centonze, Silvia Rossi, Chiara Prosperetti, Anne Tscherter, Giorgio Bernardi, Mauro Maccarrone, Paolo Calabresi. Biol Psychiatry 2005
63
25

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
Véronique M André, Carlos Cepeda, Angela Venegas, Yeranui Gomez, Michael S Levine. J Neurophysiol 2006
54
29

Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
Austen J Milnerwood, Damian M Cummings, Glenn M Dallérac, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Payam Rezaie, Kerry P S J Murphy. Hum Mol Genet 2006
112
16

Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.
Xiaofeng Gu, Chenjian Li, Weizheng Wei, Victor Lo, Shiaoching Gong, Shi-Hua Li, Takuji Iwasato, Shigeyoshi Itohara, Xiao-Jiang Li, Istvan Mody,[...]. Neuron 2005
173
16

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.
Austen J Milnerwood, Clare M Gladding, Mahmoud A Pouladi, Alexandra M Kaufman, Rochelle M Hines, Jamie D Boyd, Rebecca W Y Ko, Oana C Vasuta, Rona K Graham, Michael R Hayden,[...]. Neuron 2010
343
16

Altered information processing in the prefrontal cortex of Huntington's disease mouse models.
Adam G Walker, Benjamin R Miller, Jenna N Fritsch, Scott J Barton, George V Rebec. J Neurosci 2008
67
23

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
Melinda M Zeron, Oskar Hansson, Nansheng Chen, Cheryl L Wellington, Blair R Leavitt, Patrik Brundin, Michael R Hayden, Lynn A Raymond. Neuron 2002
451
15

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
Chiara Zuccato, Marzia Tartari, Andrea Crotti, Donato Goffredo, Marta Valenza, Luciano Conti, Tiziana Cataudella, Blair R Leavitt, Michael R Hayden, Tõnis Timmusk,[...]. Nat Genet 2003
655
15

Role of brain-derived neurotrophic factor in Huntington's disease.
Chiara Zuccato, Elena Cattaneo. Prog Neurobiol 2007
386
15


Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
96
15

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
200
15

NMDA receptor function in mouse models of Huntington disease.
C Cepeda, M A Ariano, C R Calvert, J Flores-Hernández, S H Chandler, B R Leavitt, M R Hayden, M S Levine. J Neurosci Res 2001
208
14

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.
R J Carter, L A Lione, T Humby, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 1999
696
14

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.
M Turmaine, A Raza, A Mahal, L Mangiarini, G P Bates, S W Davies. Proc Natl Acad Sci U S A 2000
348
14

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
261
14

Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.
Carlos Cepeda, Damian M Cummings, Véronique M André, Sandra M Holley, Michael S Levine. ASN Neuro 2010
61
22

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
13

The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
13

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
J A Bibb, Z Yan, P Svenningsson, G L Snyder, V A Pieribone, A Horiuchi, A C Nairn, A Messer, P Greengard. Proc Natl Acad Sci U S A 2000
236
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.